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Abstract 11 
Bacteriocins related to colicin M, acting via cleavage of the cell wall precursor lipid II, have 12 
been characterized in γ- and β-proteobacteria. Depending on the species, immunity is provided 13 
by either an inner membrane-anchored periplasmic protein or by an integral membrane 14 
protein. In Pseudomonas however, the immunity partner of colicin M-like bacteriocins remains 15 
unknown. Based on an in silico analysis in pseudomonads genomes, we here identify a gene 16 
encoding a putative immunity partner that represents a novel type of integral membrane 17 
protein (PmiA, Pseudomonas colicin M-like immunity type A). By heterologous expression of 18 
pmiA genes in susceptible strains, we show that immunity to colicin M-like bacteriocins is 19 
indeed provided by the cognate PmiA. Sequence homology among PmiA proteins is essentially 20 
absent, except for a short motif with a conserved periplasm-exposed aspartate residue. 21 
However, PmiA’s protective function is not abolished by changing this acidic residue to the 22 
uncharged alanine. Immunity by PmiAs appears promiscuous to the extent that PmiA 23 
homologues from a clade sharing less than 40% pairwise amino acid identity, equally provide 24 
protection against the bacteriocin linked to the original PmiA. This study shows that multiple 25 
immunity factors have evolved independently to silence lipid II-targeting enzymatic 26 
bacteriocins. Their relaxed bacteriocin immunization capacity contrasts to the strict specificity 27 
of immunity proteins shielding the enzymatic domain of nuclease bacteriocins. The nature of 28 
associated immune functions needs consideration when using such natural protein antibiotics 29 
or designing novel variants. 30 
 31 
1 Introduction 32 
Antibacterial proteins are currently subject of renewed interest in the search for antimicrobials with 33 
novel modes of action. As yet poorly explored potential sources of such alternative protein-based 34 
antibiotics include lytic bacteriophages (Gerstmans et al., 2016) and bacteriocinogenic strains 35 
(Schulz et al., 2015). Bacteriocins are key mediators of intra-species competition between bacteria 36 
and combine high specificity with single-hit killing potency. Prominent bacteriocin producers that 37 
target human and plant pathogenic Gram-negative bacteria are found among enterobacteria (Cascales 38 
et al., 2007; Grinter et al., 2014; Holt et al., 2013; Schulz et al., 2015) and pseudomonads (Ghequire 39 
& De Mot, 2014).  40 
Pseudomonas bacteriocins are very diverse with respect to structure and mode of action. R-type and 41 
F-type tailocins are multiprotein complexes that are evolutionary related to bacteriophage tails 42 
(Ghequire & De Mot, 2015a; Ghequire et al., 2015; Hockett et al., 2015). Lectin-like bacteriocins are 43 
constituted of a tandem of monocot mannose-binding lectin domains, and kill target cells via an 44 
unknown mechanism (Ghequire et al., 2013; Ghequire et al., 2014; McCaughey et al. 2014). S-type 45 
bacteriocins are multi-domain toxins with a modular structure similar to colicins, the bacteriocins 46 
from Escherichia coli (Cascales et al., 2007; Dingemans et al., 2016; Ghequire & De Mot, 2014; 47 
McCaughey et al., 2016). Self-inhibition of Pseudomonas aeruginosa strains producing a S-type 48 
bacteriocin (S pyocin) is circumvented by an immunity protein that transiently impedes the 49 
bacteriocin’s toxic function. This immunity complement is co-expressed with the bacteriocin, and is 50 
typically encoded downstream of the pyocin gene, on the same or opposite strand. In the case of S-51 
type bacteriocins with nuclease activity, bacteriocins are secreted as high-affinity bacteriocin-52 
immunity protein complexes (Joshi et al., 2015). Pseudomonas colicin M-like bacteriocins (PseuMs) 53 
host a lipid II-cleaving domain, homologous to the catalytic domain of colicin M (ColM) (Barreteau 54 
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et al., 2009; Barreteau et al., 2012; Grinter et al., 2012b). However, in contrast to S pyocin-immunity 55 
complexes, it is not clear how PseuM producers protect themselves. Inspection of their pseuM 56 
genomic context did not reveal homologues of cmi, the cognate immunity partner for ColM in 57 
Escherichia coli, nor were such homologues detected elsewhere in their genomes (Barreteau et al. 58 
2009). 59 
In E. coli, the cmi gene is located downstream of the bacteriocin gene on the opposite strand 60 
(Olschläger et al., 1984; Olschläger & Braun, 1987). Located in the periplasm, Cmi is anchored to 61 
the inner membrane by an amino-terminal hydrophobic α-helix, assisting in secretion but not being 62 
cleaved off. There, Cmi transiently impedes colicin M’s activity during secretion and inactivates 63 
imported ColM (Gross & Braun, 1996; Olschläger & Braun, 1987; Olschläger et al., 1991). The 64 
crystal structure of Cmi revealed the presence of four α-helices and four β-strands, and is exemplary 65 
of a YebF fold (Gérard et al., 2011, Usón et al. 2012). In Pectobacterium a cmi-like gene is located 66 
downstream and opposite of the pectocin M gene, but its protective functionality remains to be 67 
demonstrated (Grinter et al., 2012a). In most strains of Burkholderia producing colicin M-like 68 
burkhocins, immunity is mediated by bmiB genes that give rise to proteins with a small size and 69 
predicted topology similar to Cmi (Ghequire & De Mot, 2015b). However, the amino acid sequence 70 
of the periplasmic moiety of BmiB is unrelated to Cmi and lacks the characteristic YebF domain. 71 
Fewer strains carry a second type of burkhocin immunity gene (bmiA) that encodes a small integral 72 
membrane protein comprising three transmembrane helices.  73 
In this study we investigated the genomic context of pseuM genes, in search for candidate immunity 74 
partners. We demonstrate that a gene downstream of pseuM provides cognate immunity. Apart from 75 
sharing a common membrane topology reminiscent of BmiA proteins, the encoded proteins display 76 
very poor sequence conservation across PseuM-bacteriocinogenic pseudomonads. The possible role 77 
of a short semi-conserved motif in these proteins is explored, as well as the capability of PmiA 78 
proteins to immunize targeted cells in an (a)specific way.  79 
 80 
2 Materials and methods  81 
2.1 Genome searches and phylogenetic analysis 82 
PseuM bacteriocin genes in Pseudomonas genomes were identified by homology searches using the 83 
National Center for Biotechnology (NCBI) non-redundant database. The Pfam Colicin_M module 84 
PF14859 was used as a query. Genes downstream of unique pseuM bacteriocin gene products were 85 
selected for further analysis. Multiple sequence alignments were generated with MUSCLE and 86 
phylogenetic reconstructions were carried out with PhyML (1000 bootstrap replicates), implemented 87 
in Geneious v7.1.7. The JTT substitution model (Jones et al., 1992) was used for studying the 88 
evolution of a large number of amino acid sequences. Amino-terminal signal sequences were 89 
predicted by PRED-TAT (http://www.compgen.org/tools/PRED-TAT) and TOPCONS 90 
(http://topcons.cbr.su.se/). Transmembrane regions and topology were predicted by TMHMM 91 
(http://www.cbs.dtu.dk/services/TMHMM/), and TOPCONS. 92 
2.2 Bacterial strains and media 93 
Strains used in this study are listed in Table S1. Escherichia coli was grown in LB (MP Biomedicals) 94 
at 37°C, whereas Pseudomonas strains were grown with shaking at 200 rpm in Trypticase Soy Broth 95 
(TSB, BD Biosciences) and Casamino Acids Medium (CAA, BD Biosciences) at 30°C, except for P. 96 
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aeruginosa that was grown at 37°C. Growth media were supplemented with agar (1.5%, Invitrogen), 97 
filter-sterilized isopropyl-β-D-thiogalactopyranoside (IPTG, 20 µg/ml, ForMedium), kanamycin (50 98 
µg/ml, Sigma-Aldrich), or tetracycline (15-150 µg/ml, Sigma-Aldrich) when required. Strains were 99 
kept on plate at 4°C, or at -80°C in glycerol (25% v/v, Sigma-Aldrich). 100 
2.3 DNA methods and construction of plasmids 101 
Genomic DNA was collected with the Puregene Yeast/Bact. Kit B (Qiagen). Synthetic genes and 102 
primers were obtained from IDT DNA. Genes encoding bacteriocins (ERS445055_00256 from P. 103 
aeruginosa NCTC10332, PFLQ8_1129 from P. fluorescens Q8r1-96 (Landa et al., 2003) and 104 
PSPTO_0572 from P. syringae pv. tomato DC3000) and putative immunity proteins, encoded 105 
downstream, were amplified by polymerase chain reaction (PCR) with Q5 polymerase (New England 106 
Biolabs), with a T100
TM
 Thermal cycler (Bio-Rad). Q5 polymerase was used according to the 107 
supplier’s specifications. All primers are listed in Table S2. PCR fragments were purified with the 108 
Genelute PCR clean-up kit (Sigma-Aldrich), and double digested with NcoI/XhoI (1 hour at 37°C, 109 
New England Biolabs) in the case of the bacteriocin genes, and with PstI/XbaI (1 hour at 37°C, New 110 
England Biolabs) in the case of the putative immunity genes. The immunity gene amplicon of P. 111 
aeruginosa NCTC10332 was digested with PstI/EcoRI (1 hour at 37°C, New England Biolabs). 112 
Purified bacteriocin genes were ligated with T4 DNA ligase (1 hour at 37°C, Invitrogen) in pET28a 113 
(+) and putative immunity genes in shuttle vector pJB3Tc20. Ligation products were transformed to 114 
E. coli DH5α via heat shock. Standard methods were used for the preparation of competent E. coli 115 
cells and heat shock transformation of E. coli (Green and Sambrook, 2012). Transformants were 116 
initially verified for the presence of insert by PCR with Taq polymerase (New England Biolabs), 117 
using conditions as specified by the supplier. Plasmids were subsequently harvested with the 118 
Genelute HP plasmid miniprep kit (Sigma-Aldrich) and sequence confirmed for the presence of 119 
correct insert (GATC Biotech, Constance, Germany). Cloned immunity genes encompassed a 19-bp 120 
upstream region containing the predicted ribosome binding sites. Resulting plasmids are summarized 121 
in Table S1. The pET28a constructs were transformed to E. coli BL21/DE3 via heat shock, and 122 
pJB3Tc20 constructs electroporated to PseuM-susceptible Pseudomonas strains, and selected on the 123 
proper medium. Immunity genes encoding a mutation in a conserved aspartate residue were 124 
constructed via splicing by overlap extension, using pCMPG6251 (encoding the putative immunity 125 
complement of PseuMDC3000), pCMPG6252 (complement of PseuMNCTC10332), pCMPG6269 126 
(complement of PseuMQ8r1-96) as a template.  127 
2.4 Expression and purification of recombinant bacteriocins 128 
Recombinant carboxy-terminally His-tagged bacteriocins were generated in E. coli BL21(DE3) 129 
carrying pCMPG6248 (encoding PseuM from P. syringae DC3000), pCMPG6250 (encoding PseuM 130 
from P. aeruginosa NCTC10332) or pCMPG6271 (encoding PseuM from P. fluorescens Q8r1-96). 131 
5-ml overnight cultures were transferred to 500 ml LB Erlenmeyer flasks and incubated at 37°C until 132 
OD600 reached 0.7. After, cultures were cooled and supplemented with IPTG (1 mM final 133 
concentration) and incubated at 20°C for 16 hours. Next day, cells were harvested via centrifugation 134 
(20 min, 5000 g; Beckman X-15R) and frozen overnight (-20°C). Subsequently, the cell pellets were 135 
thawed, resuspended in lysis buffer (5 ml/g cell pellet; 300 mM NaCl, 50 mM NaH2PO4, 10 mM 136 
imidazole, pH 8.0) and sonicated (amplitude 20%, 10 cycles of 30 sec on/off; Branson Digital 137 
Sonifier). Samples were treated with nuclease (0.01 U/µl, 37°C, 1 hour; Invitrogen), remaining debris 138 
and insoluble proteins removed via centrifugation (30 min, 10000 g), and supernatants filtered (0.20 139 
µm, Sarstedt). Soluble fractions containing the recombinant proteins were loaded on a 5-ml HisTrap 140 
HP column (GE Healthcare) and purified by nickel affinity chromatography with an Äkta Purifier 141 
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(GE Healthcare). Matrix-bound proteins were eluted with a linear gradient of imidazole (10 mM-500 142 
mM) in lysis buffer. Fractions eluted at high imidazole concentrations were validated for the presence 143 
of recombinant protein, pooled and dialyzed to Tris buffer (50 mM, NaCl 20 mM, pH 7.5). 144 
Concentration of purified PseuMs was determined with a Genesys 10S UV-Vis Spectrophotometer 145 
(Thermo Scientific). Calculated extinction coefficients were 30612 mol/L
-1
 cm
-1
, 33062 mol/L
-1
 cm
-1
 146 
and 30367 mol/L
-1
 cm
-1
 for the His-tagged PseuM bacteriocins from strains DC3000, NCTC10332 147 
and Q8r1-96, respectively. 148 
2.5 Bacteriocin assay 149 
Bacteriocin activity was determined via spot assay. Filter-sterilized 20-µl volumes of purified 150 
recombinant proteins (1 mg/ml) were spotted onto bacterial cell lawns. After, samples were air-dried 151 
and incubated overnight. Dialysis buffer was used as a negative control. Following day, petri dishes 152 
were scored for zones lacking bacterial growth (halos). 153 
2.6 Nucleotide Accession Number 154 
GenBank accession number of the nucleotide sequence of the pseuM-pmiA pair from P. putida 155 
RW10S2 (Rokni-Zadeh et al., 2012) is KX086738. 156 
 157 
3 Results 158 
3.1 In silico search for candidate genes providing immunity to Pseudomonas colicin M-like 159 
bacteriocins 160 
Based on the genetic architecture of modular bacteriocins in Gram-negatives, it is anticipated that 161 
bacteriocin immunity genes are likely to be found in proximity of their corresponding toxin genes. 162 
By scrutiny of their genomic contexts we observed that the characterized Pseudomonas colicin M-163 
like bacteriocin genes, as well as several other predicted PseuM-encoding genes (Figure S1A), are 164 
consistently followed on the same DNA strand − at variable distances but within < 200 nucleotides − 165 
by an open reading frame, but infrequently annotated as a coding region (Table S3). Typically, G+C 166 
content of these regions (~1.8 kb) is significantly lower (41-52%) than the Pseudomonas genome 167 
averages (P. aeruginosa: 66.2%, 1647 genomes; P. fluorescens: 60.2%, 92 genomes; P. syringae: 168 
58.7%, 153 genomes). None of the deduced protein sequences contains the YebF domain signature 169 
(Pfam PF13995) as found in Cmi and the putative pectocin M immunity proteins.  170 
In fourteen Pseudomonas strains, mostly P. syringae pathovars, the encoded proteins (encompassing 171 
eight unique but very similar sequences of ~100 AAs) show only borderline homology with the 172 
burkhocin-associated BmiB immunity proteins (12-24% pairwise AA identity). However, these 173 
pseudomonad proteins, designated PmiBs, share with BmiBs two perfectly conserved cysteines 174 
(Figure S2). The PmiB and BmiB proteins are predicted to be translocated to the periplasm, albeit 175 
this appears to be achieved in different ways: instead of the BmiB amino-terminal membrane-176 
anchoring segment or Sec-dependent cleavable signal sequence, a cleavable lipoprotein signal 177 
sequence typifies PmiB. This common feature is reflected in the phylogeny of ColM domains that 178 
reveals a well-separated clade harboring both the burkhocins and this small subset of PseuM proteins 179 
(Figure S1B). 180 
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The majority of PseuM-derived ColM domains constitutes a separate clade of much more diversified 181 
sequences that are evolutionarily related to the corresponding domains in colicin M and colicin M 182 
domain-containing pectocins (Figure 1A, Figure S1B). In this second subset of PseuM-183 
bacteriocinogenic strains the bacteriocin gene is linked with a gene encoding a protein unrelated to 184 
PmiB (~137 AAs; Figure S3). This protein family, designated PmiA, features four transmembrane 185 
helices, of which the first is predicted to represent a candidate Sec- or Tat-dependent cleavable signal 186 
sequence (Figure 2A). The inferred topology, with two moieties facing the periplasm and two 187 
stretches (including the carboxy-terminus) residing in the cytoplasm, is reminiscent of the one 188 
adopted by BmiA proteins, albeit the latter lack an equivalent secretory signal sequence (Ghequire & 189 
De Mot, 2015b). No sequence homology can be detected between BmiAs and PmiAs however. 190 
Notably, four phytopathogenic strains of the P. syringae group each carry two unlinked PseuM-191 
encoding paralogues, one from each PseuM clade and clustered with, respectively, a pmiA and pmiB 192 
gene. The low level of sequence identity between these bacteriocins (~24%) combined with the 193 
different nature of the respective candidate immunity proteins argues against a common ancestry and 194 
favors their independent acquisition. 195 
In different strains, the pseuM-pmiA gene pair has been recruited to diverse genomic locations. 196 
Several of these regions correspond to mobile elements. In P. aeruginosa, the gene couple generally 197 
occurs on ExoU island A, as has previously been noted for the pseuM of P. aeruginosa JJ692 198 
(Barreteau et al., 2009). In some strains from the P. syringae group, such as isolates 642 and LMG 199 
2367, pseuM-pmiA combinations appear as a cargo gene couple in a trpE/trpG-integrated Rp4 200 
tailocin cluster (Hockett et al., 2015). In other P. syringae pathovar strains, such as DC3000 and 201 
ICMP 3923, the cargo is equally part of a Rp4-type sequence, although incomplete and apparently 202 
linked with diverged sequences. In some P. fluorescens group strains, such as P. brassicacearum 203 
NFM421 and 51MFVCI2.1, and P. fluorescens Q8r1-96, the gene pair has been recruited by a Rp4 204 
tailocin cluster as well, sandwiched between mutS and cinA (Ghequire et al., 2015; Hockett et al., 205 
2015). For other strains, such as P. veronii R4, Pseudomonas sp. BRG-100 and P. tolaasii 6264, 206 
regions flanking the pseuM-pmiA couples correspond to an unassigned prophage. The presence of 207 
bacteriocin cargo genes on mobile elements has previously been noted for lectin-like bacteriocins 208 
embedded in Pseudomonas Rp2 tailocin clusters (Ghequire et al., 2015). 209 
Some Pseudomonas strains carry a pmiA gene that is not linked to a cognate pseuM gene. The 210 
presence of pseuM remnant sequences upstream of such a pmiA orphan indicates that these strains 211 
may represent so-called cheaters that have lost the capacity of bacteriocin production but retain the 212 
associated immune function (Figure 3). For instance, in the type strain Pseudomonas lundensis (DSM 213 
6252; De Jonghe et al. 2011) a frameshift impairs functionality of a pseuM gene that has remained 214 
intact in Pseudomonas sp. AU9518. From the equivalent genomic region of type strain Pseudomonas 215 
weihenstephanensis (DSM 291166; von Neubeck et al. 2016) and some related strains (TAD18; 216 
TAA207 and DSM 28140, not included in Figure 3), most of the 3’ region of a pseuM gene has been 217 
deleted, while their pmiA genes are well conserved (>92% AA identity). No obvious pseuM 218 
sequences remain adjacent to the pmiA gene of Arabidopsis isolate Pseudomonas sp. Leaf48 (Bai et 219 
al. 2015), that is flanked by prophage genes.  220 
3.2 PmiA proteins are cognate PseuM immunity partners  221 
Previously described PseuM bacteriocins from Pseudomonas aeruginosa NCTC10332 (PaeM), 222 
Pseudomonas fluorescens Q8r1-96 (PflM) and Pseudomonas syringae pv. tomato DC3000 (PsyM), 223 
each with a downstream pmiA gene (as identified by in silico analysis described in section 3.1), were 224 
recombinantly expressed in E. coli and the His-tagged proteins purified by Ni-NTA affinity 225 
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chromatography. Strain NCTC10332 encodes a PseuM bacteriocin that shares 90% AA identity with 226 
PaeM from P. aeruginosa JJ692 (Barreteau et al., 2009). Antibacterial activity of the recombinant 227 
proteins was challenged via spot-on-lawn assay against a panel of Pseudomonas strains, and strains 228 
with a clear halo susceptibility phenotype were selected for further experiments. Such indicator 229 
strains identified for PaeM, PflM and PsyM were P. aeruginosa CPHL12447, P. fluorescens F113 230 
and P. syringae pv. lachrymans LMG 5456 (Grinter et al., 2012b), respectively.  231 
Next, the putative immunity genes from strains NCTC10332, Q8r1-96 and DC3000 were cloned in 232 
shuttle vector pJB3Tc20, and introduced in the corresponding PseuM-susceptible strains. 233 
Transformants were tested for altered PseuM sensitivity, using strains carrying empty vectors as 234 
negative controls (Table 1). When equipped with the cognate pmiA, transformants became fully 235 
insensitive to the respective bacteriocin (tested at 1 mg/ml by spot assay). When indicator strains 236 
were provided with either of the other two immunity genes, no diminished PseuM inhibition was 237 
observed. Together this indicates that PmiAs are cognate immunity partners of the bacteriocins they 238 
are associated with. Purified membrane fragments with the gene product of pmiADC3000 were analyzed 239 
via Maldi-MSMS (Poetsch et al., 2008), but no peptide fragments assignable to the PmiA of interest 240 
could be retrieved (data not shown). 241 
Since colicin M and colicin M-like bacteriocins domains exert their action in the periplasm, it is 242 
plausible that (at least part of) the periplasm-exposed moieties of PmiA proteins participate in the 243 
immunity function, directly or indirectly impeding the catalytic function of the ColM domain. 244 
Conserved residues in the immunity module may be critical in providing such property. In the mature 245 
PmiA proteins, a short well-conserved stretch with consensus motif D[T/S]XGXP precedes the 246 
second predicted transmembrane segment (Figure 4, Figure S3). No obvious sequence conservation 247 
among PmiA proteins can be detected for the shorter second periplasm-exposed loop. To further 248 
scrutinize the possible role of the first periplasmic stretch, the conserved Asp residue was mutated to 249 
Ala in the PmiAs of strains NCTC10332, Q8r1-96 and DC3000. Upon introduction of the PmiA 250 
variants in the respective indicator strains, the immunity phenotype to the respective PseuMs was 251 
evaluated. Halos were absent for all three indicator strains after bacteriocin spotting, showing the 252 
same phenotype as caused by the native immunity gene products (Table 1). This suggests that the 253 
conserved Asp residue is not instrumental to PmiA’s immunity function.  254 
3.3 Immune promiscuity among sequence-diverged PmiAs 255 
Noteworthy, sequence divergence of the PseuM-PmiA toxin-immunity pairs seems to be most 256 
pronounced among strains belonging to the P. fluorescens group. In contrast, for P. syringae 257 
pathovar isolates, high conservation of the ColM domain (at least 94% pairwise AA identity) (Figure 258 
S1A, Figure S1B) is reflected in well conserved immunity proteins (at least 84% pairwise AA 259 
identity). Previously, it was demonstrated that immunity proteins sharing high homology may 260 
provide pyocin-silencing functionality of another partner (Dingemans et al., 2016).  261 
To examine to what extent sequence divergence limits the immune function, PmiA homologues from 262 
the cluster with P. fluorescens Q8r1-96 were selected (P. brassicacearum DF41, P. fluorescens 263 
Pf29Arp, and Pseudomonas sp. Pf153), as well as some more distant PmiAs (Pseudomonas sp. 264 
strains 5 and GM21, P. fluorescens AU2390) (Figure 1B). The PmiAs from the Q8r1-96 cluster share 265 
36% to 41% AA identity with PmiAQ8r1-96. This level of sequence conservation stems mainly from 266 
the periplasm-exposed regions as well as the transmembrane helices, whereas the amino-terminal 267 
signal sequence/transmembrane helix and the cytoplasm-exposed stretches exhibit extensive 268 
sequence divergence. By comparison, the ColM domains of the PseuMs of strains DF41, Pf29Arp 269 
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and Pf153, display considerably higher sequence conservation (~69% AA identity) with PflM. 270 
Pairwise identity with the more distant PmiAs ranges from 18%-31%, corresponding with more 271 
diversified ColM domains (35-46% AA identity with PflM).  272 
These six pmiA genes were cloned in pJB3Tc20 and introduced in P. fluorescens F113, and tested for 273 
their capacity to protect from PflM activity, using empty vector and the native pmiAQ8r196 immunity 274 
gene as controls for susceptibility and immunity, respectively (Table 1). Despite only moderate 275 
pairwise identities to PmiAQ8r1-96, PmiADF41, PmiAPf153 and PmiAPf29Arp provided full cross-immunity 276 
to PflM. The more distantly related PmiAs from strains AU2390 and GM21 (with 30.9% and 23.4% 277 
AA identity, respectively) could not immunize cells against the bacteriocin, resulting in a similar 278 
phenotype as the PmiAs from P. aeruginosa NCTC10332 and P. syringae DC3000, and the control. 279 
Despite barely showing homology with PmiAQ8r1-96 (18.4% AA identity), PmiA from Pseudomonas 280 
sp. 5 conferred an intermediate immunity phenotype (turbid halo). 281 
 282 
4 Discussion 283 
In this study we demonstrated that cognate immunity to a large subset of ColM domain-containing 284 
Pseudomonas bacteriocins is provoked by the poorly conserved transmembrane protein PmiA, 285 
unrelated in sequence and topology to the Cmi protein providing immunity to colicin M in E. coli. 286 
The pmiA gene, consistently located downstream of pseuM on the same strand, is rarely annotated 287 
(Table S3). Previously, immunity to ColM domains in Burkholderia burkhocins was equally 288 
associated with a transmembrane protein (BmiA) (Ghequire & De Mot, 2015b). However, since 289 
ColM domains from bmiA- and pmiA-associated bacteriocins constitute phylogenetically distant 290 
clades, the immunity mechanism from these integral membrane proteins may be different. Further 291 
support for the existence of such evolutionarily distinct lipid II-targeting bacteriocin subsets is 292 
provided by the observation that a minor group of pseudomonad genes shares a similar immunity 293 
gene, as well as a similar ColM-domain-encoding gene, with Burkholderia. The gene organization of 294 
different ColM domain-hosting bacteriocins and their (putative) immunity genes is summarized in 295 
Figure 5. 296 
A conserved Asp residue located in a semi-conserved periplasm-exposed stretch proved not pivotal 297 
for the immunity phenotype of PmiA. Possibly, it is required for structural integrity or stability of the 298 
immunity protein, and structural analysis can give more insight in this issue. Since the periplasm-299 
exposed moieties of PmiA likely contribute to immunity, it was investigated whether cross-immunity 300 
between proteins with different extent of sequence conservation in those regions, may occur. Since 301 
this was found to be the case, even between PmiAs sharing less than 40% pairwise amino acid 302 
identity, it will be of future interest to determine which residues or structural elements actually 303 
contribute to the immunity phenotype. This will render a first indication on how and where the 304 
immunity mechanism to this toxin module may be provoked. Previously, attempts to co-crystallize 305 
colicin M and Cmi to enlighten how Cmi neutralizes ColM-mediated toxicity proved unsuccessful 306 
(Usón et al., 2012).  307 
From an evolutionary point of view, promiscuous protection by immunity genes sharing low 308 
homology may have far-reaching consequences towards competitive advantage for producer strains. 309 
It may explain why genome analysis in pseudomonads indicated that PseuMs are rather rare, as 310 
compared to DNase and RNase bacteriocins (Ghequire & De Mot, 2014). In contrast, immunity to 311 
the latter bacteriocins is provided by immunity proteins forming very specifically high-affinity 312 
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bacteriocin-immunity complexes, stabilized by conserved hydrogen bonds and hydrophobic 313 
interactions (Joshi et al., 2015; Kleanthous et al., 2016; Levin et al., 2009; Li et al., 2004; Meenan et 314 
al., 2010). PseuM bacteriocin production may therefore provide limited benefit in most 315 
environments, and hence result in lower selection pressure to maintain these bacteriocins in genomes. 316 
In addition to this, genome mining also indicated that orphan pmiA-like genes occasionally occur in 317 
Pseudomonas genomes, although it remains to be investigated whether these enable cheating. A 318 
similar observation was made for bmiA genes in Burkholderia (Ghequire & De Mot, 2015b) and S-319 
type pyocin immunity genes (Ghoul et al., 2015). 320 
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10 Figure and Table legends 456 
Figure 1. Maximum likelihood phylogenetic trees of ColM domains from pmiA-associated PseuMs 457 
and from related γ-proteobacterial bacteriocins (A), and of associated Pseudomonas PmiA immunity 458 
proteins (B). Characterized PseuM bacteriocins and cognate PmiAs are colored blue, colicin M 459 
(ColM) from E. coli is shown in red, and colicin M domain-containing pectocins (PecM1 and 460 
PecM2) in pink. PmiAs that were studied for promiscuity are shown in teal. The scale bars represent 461 
0.3 (A) and 0.8 (B) substitutions per site. Bootstrap values (percentages of 1000 replicates) higher 462 
than 50 are shown at the branches. (A) For highly homologous colicin M domains (>95% pairwise 463 
AA identity), only one representative was included for phylogenetic tree construction. Species 464 
abbreviations: Ecoli, Escherichia coli; Paer, Pseudomonas aeruginosa; Pbra, Pseudomonas 465 
brassicacearum; Pbre, Pseudomonas brenneri; Pcar, Pectobacterium carotovorum; Pflu, 466 
Pseudomonas fluorescens; Pput, Pseudomonas putida; Psp, Pseudomonas sp.; Psyr, Pseudomonas 467 
syringae; Psyr cory, P. syringae pv. coryli; Psyr tom, P. syringae pv. tomato; Ptol, Pseudomonas 468 
tolaasii. 469 
Figure 2. Membrane topology model of integral membrane proteins PmiA and BmiA, and 470 
membrane-anchored proteins Cmi, PmiB and BmiB, providing immunity to the activity of the ColM 471 
domain. PmiA from Pseudomonas has four predicted transmembrane helices, the first of which may 472 
represent a Sec- or Tat-dependent signal sequence (box). BmiA from Burkholderia carries three 473 
transmembrane helices. Cmi has a periplasmic YebF domain and is anchored in the inner membrane 474 
(IM) via an amino-terminal helix. PmiB and BmiB are equally anchored in the IM, and carry 475 
homologous periplasmic domains. “N” depicts the amino-terminus.  476 
Figure 3. Genomic context of orphan pmiA genes in pseudomonads. Syntenic regions carrying a 477 
pmiA homologue associated with a full-length PseuM-encoding gene are shown for Pseudomonas sp. 478 
strains AU9518 (A),  GM55 (B), NFACC04-2 (C), and NFACC51 (D). Synteny between these 479 
predicted bacteriocin producers and phylogenetically related cheaters lacking a (functional) 480 
bacteriocin gene is highlighted by upstream and downstream ORFs (arrows) shown in the same 481 
color. The grey-colored ORFs (D) reflect a local lack of synteny. Remnants of the respective pseuM 482 
genes are represented by white-coloured rounded shapes corresponding to a frameshifted pseuM 483 
(position marked by a dotted vertical line) or a truncated residual N- or C-terminal fragment. For 484 
Pseudomonas strains ERGS4:02 (E) and Leaf48 (F), no strain with a closely related pmiA homologue 485 
and syntenic flanking region could be identified. Species abbreviations: Pfre, Pseudomonas 486 
frederikbergensis; Plun, Pseudomonas lundensis; Pwei, Pseudomonas weihenstephanensis. Other 487 
abbreviations are as in Figure 1.  488 
Figure 4. Multiple sequence alignment of the semi-conserved stretch in PmiA proteins, predicted to 489 
be oriented towards the periplasmic space. Pseudomonas species abbreviations are as in Figure 1. 490 
Grey shading reflects the degree of conservation. The conserved Asp residue that was mutated is 491 
boxed in green. 492 
Figure 5. Schematic gene organizations of ColM domain-containing bacteriocins and (putative) 493 
immunity genes (if present). The arrows correspond with the gene orientations and the color legend 494 
describes the indicated domains and type of immunity gene. Predicted immunity genes, based on 495 
homology with characterized immunity factors, are delineated by a dashed line. Species 496 
abbreviations are as in Figure 1. Other abbreviations: Bamb, Burkholderia ambifaria; Bglu, 497 
Burkholderia glumae. 498 
 499 
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Table 1. Heterologous expression of pmiA genes in PseuM-susceptible strains. Indicator strains were 500 
transformed with shuttle vector pJB3Tc20 (control, without insert) or with pJB3Tc20-derived 501 
plasmids equipped with different pmiA genes, and tested for (altered) susceptibility to their respective 502 
PseuM via bacteriocin spot assay. +, sensitive; -, insensitive; T, turbid halo. The species used as 503 
source of immunity protein are specified with the respective strain names indicated as PmiA 504 
subscript (NA, not applicable). Asterisks define mutated immunity proteins (Asp to Ala). Strain 505 
LMG 5456 carrying a plasmid equipped with pmiAQ8r1-96 could not be obtained. 506 
Indicator strain 
PmiA immunity protein PseuM bacteriocin 
Species Gene product 
PaeM 
P. aeruginosa 
NCTC10332 
PflM 
P. fluorescens 
Q8r1-96 
PsyM 
P. syringae pv. 
tomato DC3000 
P. aeruginosa CPHL12447 P. aeruginosa PmiANCTC10332 -   
  PmiA*NCTC10332 -   
 P. fluorescens PmiAQ8r1-96 +   
 P. syringae PmiADC3000 +   
 NA Control +   
P. fluorescens F113 P. aeruginosa PmiANCTC10332  +  
 P. brassicacearum PmiADF41  -  
 P. fluorescens PmiAQ8r1-96  -  
  PmiA*Q8r1-96  -  
  PmiAAU2390  +  
  PmiAPf29Arp  -  
 P. syringae PmiADC3000  +  
 Pseudomonas sp. PmiA5  T  
  PmiAGM21  +  
  PmiAPf153  -  
 NA Control  +  
P. syringae LMG 5456 P. aeruginosa PmiANCTC10332   + 
 P. syringae PmiADC3000   - 
  PmiA*DC3000   - 
 NA Control   + 
 507 
 508 
 509 
 510 
 511 
 512 
 513 
 514 
 515 
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11 Supplementary tables and figures 518 
Table S1. Strains and plasmids used in this study. 519 
Table S2. Primers used in this study. 520 
Table S3. Colicin M-like bacteriocin genes present in genome sequences of pseudomonads. NA: not 521 
annotated. PseuM genes present in gene context consisting of phage-like genes are marked with “Y” 522 
(phage-like and tailocin context), others with “N”. Pseudomonads containing a putative orphan pmiA 523 
are colored red. 524 
 525 
 526 
 527 
 528 
Figure S1. (A) Multiple sequence alignment of ColM domains derived from unique PseuM proteins 529 
from Pseudomonas spp. Abbreviations for species names are as in Figure 1. Other abbreviations: 530 
Pced, Pseudomonas cedrina; Pcor ory, Pseudomonas coronafaciens pv. oryzae; Pden, Pseudomonas 531 
denitrificans; Pkor, Pseudomonas koreensis; Ppro, Pseudomonas protegens; Psyr ace-cori-mors-syr-532 
the, Pseudomonas syringae aceris-coriandricola-morsprunorum-syringae-theae; Pthi, Pseudomonas 533 
thivervalensis; Pver, Pseudomonas veronii. Grey shading reflects the degree of conservation. (B) 534 
Unrooted maximum likelihood phylogenetic tree of ColM domains of pseudomonads (black) from 535 
panel (A) and previously characterized ColM domain-carrying bacteriocins from other β- and γ-536 
proteobacteria: colicin M (ColM, red) from E. coli, pectocin M1 and M2 from Pectobacterium spp. 537 
(PecM1/PecM2, pink), burkhocin M1 and M2 from Burkholderia spp. (BurM1/BurM2, grey). 538 
Pseudomonas abbreviations as in (A). The clade of Pseudomonas ColM domains from bacteriocins 539 
linked with a pmiA-type immunity gene and pmiB-type immunity gene are in a red arc and a blue 540 
ellipse, respectively. Other abbreviations: Bamb, Burkholderia ambifaria; Ecoli, Escherichia coli; 541 
Pcar, Pectobacterium carotovorum. The scale represents 0.6 substitutions per site. Bootstrap values 542 
(percentages of 1000 replicates) are not shown for visibility. 543 
Figure S2. Multiple sequence alignment of BmiB (Burkholderia spp.) and unique PmiB 544 
(Pseudomonas spp.) proteins. Grey shading indicates the degree of conservation. Abbreviations for 545 
Burkholderia species names: Bubo, Burkholderia ubonensis; Bcon, Burkholderia contaminans; 546 
Bamb, Burkholderia ambifaria; Bokl, Burkholderia oklahomensis; Bcep, Burkholderia cepacia; 547 
Bcen, Burkholderia cenocepacia; Bpyr, Burkholderia pyrrocinia; Burk, Burkholderia sp. 548 
Pseudomonas abbreviations are as in Figure 1 and Figure S1. Predicted transmembrane helices are 549 
boxed in blue, Sec- or Tat-dependent signal sequences in red and lipoprotein signal sequences in 550 
yellow. Two conserved cysteine residues are highlighted in green.  551 
Figure S3. Multiple sequence alignment of unique PmiA proteins. Predicted transmembrane helices 552 
are boxed in blue, Sec- or Tat-dependent signal sequences in red. Grey shading indicates the degree 553 
of conservation. Pseudomonas species abbreviations are as in Figure S1. This multiple sequence 554 
alignment was used for construction of phylogenetic tree in Figure 1B. 555 
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